Skip To Main Content
Alberto Bardelli on Muck Rack

Alberto Bardelli

As seen in: Nature, ScienceDirect, Genome Medicine, Cell Press, Cell Reports Medicine, Cancer Discovery, Cancer Treatment Reviews
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alberto

Contact Alberto, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Adaptive plasticity in targeted therapy

|
By Vito Amodio, Giorgio Patelli, Alberto Bardelli
| Cell Press Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Patelli, G. ∙ Tosi, F. ∙ Amatu, A. ... Strategies to tackle RAS-mutated metastatic colorectal cancer ESMO Open. 2021; 6, 100156 2. Prahallad, A. ∙ Sun, C. ∙ Huang, S. ... Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR Nature. 2012; 483:100-103 3. Amodio, V. ∙ Yaeger, R. ∙ Arcella, P. ... EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer Cancer Discov.
Open in Who Shared Issue with article?

The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets

|
By Pietro Paolo Vitiello, Alberto Bardelli, Hannah Garner, Shanshan Zhang
| ScienceDirect Verified
Author contributions Conceptualization, C.R.J. and T.G.; samples, B.A.W., B.S., C.S., D.d.J., D.K.-L., D.N., E.G., G.J.L.H.v.L., G.K., H.W.M.vL., I.V.B., J.C., J.L., J.N.M.I., J.P.M., J.P.P.M., J.W.M.M., M.F.B., M.L., M.M., M.Y., N.C.T.v.G., R.D.M.S., R.E.K., R.H.B., T.L., T.Y.S.L.L., V.C., W.v.H., J.J., and X.Z.; methodology, B.S., J.L., M.L., R.R.d.G.-d.H., S.R.P., and T.S.; software, J.C.K., M.L., and T.V.P.; validation, M.L. and T.V.P.; formal analysis, A.V.-M., A.H., F.B., F.R., I.V.B.,...
Open in Who Shared Issue with article?

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models

|
By Pietro Paolo Vitiello, Benoit Rousseau, Rosaria Chilà, Vito Amodio, Gaia Grasso, Achille Anselmo, Francesca Clemente, Giuseppe Rospo, Simona Lamba, Alice Bartolini, Federica Pisati, Claudio Tripodo, Noemi Congiusta, Mariangela Russo, Giovanni Crisafulli, Federica Di Nicolantonio, Giovanni Germano, Luis Diaz, Alberto Bardelli, Paolo Battuello, Vittorio Battaglieri, Sharon Scardellato
| Cell Press Verified
Keywords cytotoxic chemotherapy immune surveillance chemotherapy cisplatin temozolomide colorectal cancer neoantigens immune checkpoint blockade immune rewiring mismatch repair modulation Introduction Immune checkpoint blockade (ICB) with programmed cell death protein 1 (PD-1) ± cytotoxic T lymphocyte antigen 4 (CTLA-4) blocking antibodies has shown efficacy in colorectal cancers (CRCs) characterized by either deficient mismatch repair (MMRd) or inactivating mutations in the proofreading...
Open in Who Shared Issue with article?
See all 22 articles